๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Enzyme replacement therapy for mild patients with Gaucher disease

โœ Scribed by Ari Zimran; Yaron Ilan; Deborah Elstein

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
68 KB
Volume
84
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Correction of neutrophil chemotaxis defe
Correction of neutrophil chemotaxis defect in patients with gaucher disease by low-dose enzyme replacement therapy
โœ Dr. A. Zimran; A. Abrahamov; M. Aker; Y. Matzner ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 192 KB

We have recently described a chemotactic defect in severely afflicted Gaucher disease patients. Two of the patients were treated with low-dose intravenous enzyme replacement (Ceredase). Marked improvement in their hematological status, organomegaly, and growth was observed. In addition, their chemot

Acute lymphoblastic leukemia in a patien
Acute lymphoblastic leukemia in a patient with type 1 Gaucher disease developing 1 year after discontinuation of enzyme replacement therapy
โœ Aditi Ranade; Sorin Selegean; Gagangeet Sandhu; Violette Ghali; Vijay P. Shah ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 215 KB

Higher rates of venous thromboembolism for Black-Americans are likely due to lower serum ## 25-hydroxyvitamin D levels To the editor: The recent paper on disparities of thromboembolism in the United States concluded that heritability may be important in the etiology of venous thromboembolism amon

55-Base pair deletion in certain patient
55-Base pair deletion in certain patients with Gaucher disease complicates screening for common Gaucher alleles
โœ Tayebi, N.; Stern, H.; Dymarskaia, I.; Herman, J.; Sidransky, E. ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 397 KB ๐Ÿ‘ 1 views

Mutations in the glucocerebrosidase gene which result in Gaucher disease can originate from the highly homologous glucocerebrosidase pseudogene. A 55-bp deletion in exon 9, which corresponds to a 55-bp segment absent from the pseudogene, has been identified in patients with Gaucher disease. We have